Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bauer, R. L.
Right arrow Articles by Douglass, H. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bauer, R. L.
Right arrow Articles by Douglass, H. O., Jr

Annals of Surgical Oncology, Vol 1, Issue 3 183-188, Copyright © 1994 by Society of Surgical Oncology

ARTICLES

Adenocarcinoma of the small intestine: 21-year review of diagnosis, treatment, and prognosis

R. L. Bauer, M. L. Palmer, A. M. Bauer, H. R. Nava and H. O. Douglass Jr
Roswell Park Cancer Institute, Department of Surgical Oncology, Buffalo, NY 14263.

BACKGROUND: The purpose of this study was to evaluate the tumor characteristics and treatment associated with an improved overall survival in patients with adenocarcinoma of the small intestine. METHODS: The records of all patients with primary adenocarcinoma of the small bowel seen between January 1971 and December 1991 were reviewed retrospectively. The study comprised 38 patients, 22 (58%) with duodenal tumors, 11 (29%) with jejunal tumors, and five (13%) with ileal tumors. RESULTS: Although not statistically significant, the patients with duodenal adenocarcinoma lived longer than the patients with jejunal or ileal lesions (p = 0.77). The overall survival was 23% and seemed to correlate best with absence of lymph node metastases (p = 0.04) and pancreaticoduodenectomy for localized duodenal tumors (p = 0.04). The patient's age, duration of symptoms, disease-free interval, tumor location, type of recurrence, and histologic grade did not significantly influence survival. CONCLUSIONS: The lethality of small-intestinal adenocarcinoma appears to be related to a delay in diagnosis and treatment. When a definitive surgical procedure is performed before lymph node metastases appear, the patient's chance for long-term survival is greatly improved.


This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
S. Agrawal, E. C. McCarron, J. F. Gibbs, H. R. Nava, G. E. Wilding, and A. Rajput
Surgical Management and Outcome in Primary Adenocarcinoma of the Small Bowel
Ann. Surg. Oncol., August 1, 2007; 14(8): 2263 - 2269.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. D. Potter, J. A. Murray, J. H. Donohue, L. J. Burgart, D. M. Nagorney, J. A. van Heerden, M. F. Plevak, A. R. Zinsmeister, and S. N. Thibodeau
The Role of Defective Mismatch Repair in Small Bowel Adenocarcinoma in Celiac Disease
Cancer Res., October 1, 2004; 64(19): 7073 - 7077.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
M. S. Talamonti, L. H. Goetz, S. Rao, and R. J. Joehl
Primary Cancers of the Small Bowel: Analysis of Prognostic Factors and Results of Surgical Management
Arch Surg, May 1, 2002; 137(5): 564 - 571.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the Society of Surgical Oncology.